{"pub": "investing.com", "url": "https://au.investing.com/news/stock-market-news/briefpharma-mar-signs-new-deal-with-sta-to-commercialize-yondelis-in-australia-new-zealand-and-southeast-asia-1971884", "downloaded_at": "2019-10-14 06:37:54.478156+00:00", "title": "BRIEF-Pharma Mar Signs New Deal With STA To Commercialize Yondelis In Australia, New Zealand And Southeast Asia", "language": "en", "text": "BRIEF-Pharma Mar Signs New Deal With STA To Commercialize Yondelis In Australia, New Zealand And Southeast Asia\n\nStock Markets 27 minutes ago (Oct 14, 2019 17:10)\n\n\u00a9 Reuters. BRIEF-Pharma Mar Signs New Deal With STA To Commercialize Yondelis In Australia, New Zealand And Southeast Asia Oct 14 (Reuters) - Pharma Mar SA : * SIGNS A NEW AGREEMENT WITH SPECIALISED THERAPEUTICS ASIA, PTE. LTD (STA) FOR COMMERCIALIZATION OF YONDELIS IN AUSTRALIA, NEW ZEALAND AND SOUTHEAST ASIA * SAYS TO RECEIVE ADVANCE PAYMENT AND MAY RECEIVE ADDITIONAL INCOME, INCLUDING PAYMENTS FOR REGULATORY MILESTONES * TO RETAIN EXCLUSIVE PRODUCTION RIGHTS ON THE PRODUCT AND WILL SELL THE PRODUCT TO STA FOR COMMERCIAL AND CLINICAL USE\n\nBRIEF-Pharma Mar Signs New Deal With STA To Commercialize Yondelis In Australia, New Zealand And Southeast Asia", "description": "BRIEF-Pharma Mar Signs New Deal With STA To Commercialize Yondelis In Australia, New Zealand And Southeast Asia", "authors": [], "top_image": "https://i-invdn-com.akamaized.net/news/LYNXNPEB5S0BB_L.jpg", "published_at": "2019-10-14"}